We are looking for young people 2–17 years old to join a Crohn’s disease clinical research study to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or moderately to severely active ulcerative colitis (including associated symptoms such as cramping, blood in the stool, bloody stool, weight loss and/or liver disease), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the IBD clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child is eligible.
